IFNA1 and relapsing-remitting multiple sclerosis: Previously, we demonstrated significant differences in the expression of type I IFN-induced genes between untreated RRMS patients.[14] Here we investigated whether there is a relationship between the differential in vivo responsiveness to IFNß and baseline expression levels of IFN-induced genes.